Cellebrite DI closed at $12.37 on Nov 6, down 0.08%, 35.8% below its 52-week closing high. Volume of 841.1K shares was 0.53× its 20-day average (below normal).
Split-adjusted performance: +9.1% over one month, -9.2% over six months, -22.9% over one year.
Short interest was 7.2M shares at the Oct 15 settlement, down 10.7% from the prior report (5.6% of float, 3.8 days to cover).
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations.
What is CLBT's market cap?
$3.11B, based on the Nov 6 close of $12.37.
Does Cellebrite DI pay a dividend?
No regular cash dividend has been paid in the last year.
How much of CLBT is sold short?
7.2M shares, 5.6% of float, as of Oct 15, 2026.
About Cellebrite DI
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
